The immunoregulatory landscape of human tuberculosis granulomas.


Journal

Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354

Informations de publication

Date de publication:
02 2022
Historique:
received: 25 05 2021
accepted: 14 12 2021
pubmed: 22 1 2022
medline: 19 2 2022
entrez: 21 1 2022
Statut: ppublish

Résumé

Tuberculosis (TB) in humans is characterized by formation of immune-rich granulomas in infected tissues, the architecture and composition of which are thought to affect disease outcome. However, our understanding of the spatial relationships that control human granulomas is limited. Here, we used multiplexed ion beam imaging by time of flight (MIBI-TOF) to image 37 proteins in tissues from patients with active TB. We constructed a comprehensive atlas that maps 19 cell subsets across 8 spatial microenvironments. This atlas shows an IFN-γ-depleted microenvironment enriched for TGF-β, regulatory T cells and IDO1

Identifiants

pubmed: 35058616
doi: 10.1038/s41590-021-01121-x
pii: 10.1038/s41590-021-01121-x
pmc: PMC8810384
doi:

Substances chimiques

B7-H1 Antigen 0
Cytokines 0
Indoleamine-Pyrrole 2,3,-Dioxygenase 0

Types de publication

Journal Article Meta-Analysis Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

318-329

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI134810
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI057229
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI109662
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI134245
Pays : United States
Organisme : NIAID NIH HHS
ID : R33 AI138280
Pays : United States
Organisme : NCI NIH HHS
ID : F31 CA246880
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI167903
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI125197
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007290
Pays : United States
Organisme : NIH HHS
ID : P51 OD011133
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2022. The Author(s).

Références

World Health Organization. Global Tuberculosis Report 2020 https://www.who.int/publications/i/item/9789240013131 (WHO, 2020).
Cohen, S. B. et al. Alveolar macrophages provide an early Mycobacterium tuberculosis niche and initiate dissemination. Cell Host Microbe 24, 439–446 (2018).
pubmed: 30146391 pmcid: 6152889 doi: 10.1016/j.chom.2018.08.001
Wolf, A. J. et al. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J. Immunol. 179, 2509–2519 (2007).
doi: 10.4049/jimmunol.179.4.2509 pubmed: 17675513
Bold, T. D. & Ernst, J. D. Who benefits from granulomas, mycobacteria or host? Cell 136, 17–19 (2009).
pubmed: 19135882 pmcid: 4214211 doi: 10.1016/j.cell.2008.12.032
Davis, J. M. & Ramakrishnan, L. The role of the granuloma in expansion and dissemination of early tuberculous infectionspan. Cell 136, 37–49 (2009).
pubmed: 19135887 pmcid: 3134310 doi: 10.1016/j.cell.2008.11.014
Ramakrishnan, L. Revisiting the role of the granuloma in tuberculosis. Nat. Rev. Immunol. 12, 352–366 (2012).
doi: 10.1038/nri3211 pubmed: 22517424
Cadena, A. et al. Heterogeneity in tuberculosis.Nat. Rev. Immunol. 17, 691–702 (2017).
pubmed: 28736436 pmcid: 6247113 doi: 10.1038/nri.2017.69
Subbian, S. et al. Lesion-specific immune response in granulomas of patients with pulmonary tuberculosis: a pilot study. PLoS ONE 10, e0132249 (2015).
pubmed: 26133981 pmcid: 4489805 doi: 10.1371/journal.pone.0132249
Coleman, M. T. et al. Early changes by (18)fluorodeoxyglucose positron emission tomography coregistered with computed tomography predict outcome after Mycobacterium tuberculosis infection in cynomolgus macaques. Infect. Immun. 82, 2400–2404 (2014).
pubmed: 24664509 pmcid: 4019174 doi: 10.1128/IAI.01599-13
Lin, P. L. et al. Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing. Nat. Med. 20, 75–79 (2013).
pubmed: 24336248 pmcid: 3947310 doi: 10.1038/nm.3412
Martin, C. J. et al. Digitally Barcoding Mycobacterium tuberculosis reveals in vivo infection dynamics in the macaque model of tuberculosis. MBio 8, e00312–e00317 (2017).
pubmed: 28487426 pmcid: 5424202 doi: 10.1128/mBio.00312-17
Carow, B. et al. Spatial and temporal localization of immune transcripts defines hallmarks and diversity in the tuberculosis granuloma. Nat. Commun. 10, 1–15 (2019).
doi: 10.1038/s41467-019-09816-4
Marakalala, M. J. et al. Inflammatory signaling in human tuberculosis granulomas is spatially organized. Nat. Med. 22, 531–538 (2016).
pubmed: 27043495 pmcid: 4860068 doi: 10.1038/nm.4073
Kauffman, K. D. et al. Defective positioning in granulomas but not lung-homing limits CD4 T-cell interactions with Mycobacterium tuberculosis-infected macrophages in rhesus macaques. Mucosal Immunol. 11, 462–473 (2018).
doi: 10.1038/mi.2017.60 pubmed: 28745326
Ernst, J. D., Cornelius, A., Desvignes, L., Tavs, J. & Norris, B. A. Limited antimycobacterial efficacy of epitope peptide administration despite enhanced antigen-specific CD4 T-cell activation. J. Infect. Dis. 218, 1653–1662 (2018).
pubmed: 29548008 pmcid: 6173573 doi: 10.1093/infdis/jiy142
Keren, L. et al. MIBI-TOF: a multiplexed imaging platform relates cellular phenotypes and tissue structure. Sci. Adv. 5, eaax5851 (2019).
pubmed: 31633026 pmcid: 6785247 doi: 10.1126/sciadv.aax5851
Krishnan, N., Robertson, B. D. & Thwaites, G. The mechanisms and consequences of the extra-pulmonary dissemination of Mycobacterium tuberculosis. Tuberculosis 90, 361–366 (2010).
doi: 10.1016/j.tube.2010.08.005 pubmed: 20829117
Keren, L. et al. A structured tumor-immune microenvironment in triple negative breast cancer revealed by multiplexed ion beam imaging. Cell 174, 1373–1387 (2018).
pubmed: 30193111 pmcid: 6132072 doi: 10.1016/j.cell.2018.08.039
Van Valen, D. A. et al. Deep learning automates the quantitative analysis of individual cells in live-cell imaging experiments. PLoS Comput. Biol. 12, e1005177 (2016).
pubmed: 27814364 pmcid: 5096676 doi: 10.1371/journal.pcbi.1005177
Bannon, D. et al. DeepCell Kiosk: scaling deep learning–enabled cellular image analysis with Kubernetes. Nat. Methods 18, 43–45 (2021).
pubmed: 33398191 pmcid: 8759612 doi: 10.1038/s41592-020-01023-0
Van Gassen, S. et al. FlowSOM: using self-organizing maps for visualization and interpretation of cytometry data. Cytom. Part A 87, 636–645 (2015).
doi: 10.1002/cyto.a.22625
Polena, H. et al. Mycobacterium tuberculosis exploits the formation of new blood vessels for its dissemination. Sci. Rep. 6, 33162 (2016).
pubmed: 27616470 pmcid: 5018821 doi: 10.1038/srep33162
Oehlers, S. H. et al. Interception of host angiogenic signalling limits mycobacterial growth. Nature 517, 612–615 (2015).
doi: 10.1038/nature13967 pubmed: 25470057
Girvan, M. & Newman, M. E. J. Community structure in social and biological networks. Proc. Natl Acad. Sci. USA 99, 7821–7826 (2002).
pubmed: 12060727 pmcid: 122977 doi: 10.1073/pnas.122653799
Chen, Z., Soifer, I., Hilton, H., Keren, L. & Jojic, V. Modeling multiplexed images with spatial-LDA reveals novel tissue microenvironments. J. Comput. Biol. 27, 1204–1218 (2020).
pubmed: 32243203 pmcid: 7415889 doi: 10.1089/cmb.2019.0340
Shi, J. et al. PD-1 controls follicular T helper cell positioning and function. Immunity 49, 264–274 (2018).
pubmed: 30076099 pmcid: 6104813 doi: 10.1016/j.immuni.2018.06.012
Ulrichs, T. et al. Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung. J. Pathol. 204, 217–228 (2004).
doi: 10.1002/path.1628 pubmed: 15376257
Difazio, R. M. et al. Active transforming growth factor-β is associated with phenotypic changes in granulomas after drug treatment in pulmonary tuberculosis. DARU, J. Pharm. Sci. 24, 6 (2016).
Krystel-Whittemore, M. Mast cell: a multi-functional master cell. Front. Oncol. 6, 620 (2016).
Gideon, H. P. et al. Single-cell profiling of tuberculosis lung granulomas reveals functional lymphocyte. Preprint at bioRxiv https://doi.org/10.1101/2020.10.24.352492 (2020).
Shen, L. et al. PD-1/PD-L pathway inhibits M.tb-specific CD4+ T-cell functions and phagocytosis of macrophages in active tuberculosis. Sci. Rep. 6, 38362 (2016).
pubmed: 27924827 pmcid: 5141449 doi: 10.1038/srep38362
Mehra, S. et al. Granuloma correlates of protection against tuberculosis and mechanisms of immune modulation by Mycobacterium tuberculosis. J. Infect. Dis. 207, 1115–1127 (2013).
doi: 10.1093/infdis/jis778 pubmed: 23255564
Munn, D. H. & Mellor, A. L. IDO in the tumor microenvironment: inflammation, counter-regulation, and tolerance. Trends Immunol. 37, 193–207 (2016).
pubmed: 26839260 pmcid: 4916957 doi: 10.1016/j.it.2016.01.002
Gautam, U. S. et al. In vivo inhibition of tryptophan catabolism reorganizes the tuberculoma and augments immune-mediated control of Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 115, E62–E71 (2018).
doi: 10.1073/pnas.1711373114 pubmed: 29255022
Jurado, J. O. et al. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis. J. Immunol. 181, 116–125 (2008).
doi: 10.4049/jimmunol.181.1.116 pubmed: 18566376
Mulder, K. Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease. Immunity 54, 1883–1900 (2021).
doi: 10.1016/j.immuni.2021.07.007 pubmed: 34331874
Veglia, F., Perego, M. & Gabrilovich, D. Myeloid-derived suppressor cells coming of age review-article. Nat. Immunol. 19, 108–119 (2018).
pubmed: 29348500 pmcid: 5854158 doi: 10.1038/s41590-017-0022-x
Gideon, H. P., Phuah, J., Junecko, B. A. & Mattila, J. T. Neutrophils express pro- and anti-inflammatory cytokines in granulomas from Mycobacterium tuberculosis-infected cynomolgus macaques. Mucosal Immunol. 12, 1370–1381 (2019).
pubmed: 31434990 pmcid: 6824993 doi: 10.1038/s41385-019-0195-8
Kanamori, M., Nakatsukasa, H., Okada, M., Lu, Q. & Yoshimura, A. Induced regulatory T cells: their development, stability, and applications. Trends Immunol. 37, 803–811 (2016).
pubmed: 27623114 doi: 10.1016/j.it.2016.08.012
Scott-Browne, J. P. et al. Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J. Exp. Med. 204, 2159–2169 (2007).
pubmed: 17709423 pmcid: 2118702 doi: 10.1084/jem.20062105
Guyot-Revol, V., Innes, J. A., Hackforth, S., Hinks, T. & Lalvani, A. Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am. J. Respir. Crit. Care Med. 173, 803–810 (2006).
doi: 10.1164/rccm.200508-1294OC pubmed: 16339919
Green, A. M. et al. CD4 + regulatory T cells in a cynomolgus macaque model of Mycobacterium tuberculosis infection. J. Infect. Dis. 202, 533–541 (2010).
doi: 10.1086/654896 pubmed: 20617900
Bagaitkar, J. Cellular dynamics of resolving inflammation. Blood 124, 1701–1703 (2014).
pubmed: 25214196 pmcid: 4162102 doi: 10.1182/blood-2014-07-589341
Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15, 486–499 (2015).
pubmed: 26205583 pmcid: 4889009 doi: 10.1038/nri3862
Wong, E. A. Low levels of T cell exhaustion in tuberculous lung granulomas. Infect. Immun. 86, e00426-18 (2018).
pubmed: 29891540 pmcid: 6105875 doi: 10.1128/IAI.00426-18
Gern, B. H. et al. TGFβ restricts expansion, survival, and function of T cells within the tuberculous granuloma. Cell Host Microbe 29, 594–606 (2021).
doi: 10.1016/j.chom.2021.02.005 pubmed: 33711270 pmcid: 8624870
Baughman, R. P. Sarcoidosis.Lancet 361, 1111–1118 (2003).
doi: 10.1016/S0140-6736(03)12888-7 pubmed: 12672326
Koth, L. L. et al. Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis. Am. J. Respir. Crit. Care Med. 184, 1153–1163 (2011).
pubmed: 21852540 pmcid: 3262024 doi: 10.1164/rccm.201106-1143OC
Maertzdorf, J. et al. Common patterns and disease-related signatures in tuberculosis and sarcoidosis. Proc. Natl Acad. Sci. USA 109, 7853–7858 (2012).
pubmed: 22547807 pmcid: 3356621 doi: 10.1073/pnas.1121072109
Rossi, G. A. et al. Helper T-lymphocytes in pulmonary sarcoidosis: functional analysis of a lung T-cell subpopulation in patients with active disease. Am. Rev. Respir. Dis. 133, 1086–1090 (1986).
Facco, M. et al. Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax 66, 144–150 (2011).
doi: 10.1136/thx.2010.140319 pubmed: 21139119
Haynes, W. A. Empowering multi-cohort gene expression analysis to increase reproducibility. Pac. Symp. Biocomput. 22, 144–153 (2017).
pubmed: 27896970
Sweeney, T. E., Haynes, W. A., Vallania, F., Ioannidis, J. P. & Khatri, P. Methods to increase reproducibility in differential gene expression via meta-analysis. Nucleic Acids Res. (2017).
Scriba, T. J. et al. Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease. PLoS Pathog. 13, e1006687 (2017).
pubmed: 29145483 pmcid: 5689825 doi: 10.1371/journal.ppat.1006687
Zak, D. E. et al. A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet 387, 2312–2322 (2016).
pubmed: 27017310 pmcid: 5392204 doi: 10.1016/S0140-6736(15)01316-1
Warsinske, H., Vashisht, R. & Khatri, P. Host-response-based gene signatures for tuberculosis diagnosis: a systematic comparison of 16 signatures. PLoS Med. 16, e1002786 (2019).
pubmed: 31013272 pmcid: 6478271 doi: 10.1371/journal.pmed.1002786
Roy Chowdhury, R. et al. A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes. Nature 560, 644–648 (2018).
doi: 10.1038/s41586-018-0439-x pubmed: 30135583
Malherbe, S. T. et al. Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure. Nat. Med. 22, 1094–1100 (2016).
pubmed: 27595324 pmcid: 5053881 doi: 10.1038/nm.4177
Collins, J. M. et al. Tryptophan catabolism reflects disease activity in human tuberculosis. JCI Insight 5, e137131 (2020).
pmcid: 7259525 doi: 10.1172/jci.insight.137131
Elkington, P. T., Bateman, A. C., Thomas, G. J. & Ottensmeier, C. H. Implications of tuberculosis reactivation after immune checkpoint inhibition. Am. J. Respiratory Crit. Care Med. 198, 1451–1453 (2018).
doi: 10.1164/rccm.201807-1250LE
Flynn, J. L., Goldstein, M. M., Triebold, K. J., Koller, B. & Bloom, B. R. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl Acad. Sci. USA 89, 12013–12017 (1992).
pubmed: 1465432 pmcid: 50688 doi: 10.1073/pnas.89.24.12013
Lalvani, A. et al. Human cytolytic and interferon γ-secreting CD8
pubmed: 9419365 pmcid: 18198 doi: 10.1073/pnas.95.1.270
Li, M. O., Sanjabi, S. & Flavell, R. A. A. Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25, 455–471 (2006).
doi: 10.1016/j.immuni.2006.07.011 pubmed: 16973386
Jarnicki, A. G., Lysaght, J., Todryk, S. & Mills, K. H. G. Suppression of antitumor immunity by IL-10 and TGF-β-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4 + and CD8 + regulatory T cells. J. Immunol. 177, 896–904 (2006).
doi: 10.4049/jimmunol.177.2.896 pubmed: 16818744
Wong, E. A. et al. IL-10 impairs local immune response in lung granulomas and lymph nodes during early Mycobacterium tuberculosis infection. J. Immunol. 204, 644–659 (2020).
doi: 10.4049/jimmunol.1901211 pubmed: 31862711
McNab, F. W. et al. Programmed death ligand 1 is over-expressed by neutrophils in the blood of patients with active tuberculosis. Eur. J. Immunol. 41, 1941–1947 (2011).
pubmed: 21509782 pmcid: 3179592 doi: 10.1002/eji.201141421
Matthew, P. R. Berry et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466, 973–977 (2010).
doi: 10.1038/nature09247
Havel, J. J., Chowell, D. & Chan, T. A. The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy. Nat. Rev. Cancer 19, 133–150 (2019).
pubmed: 30755690 pmcid: 6705396 doi: 10.1038/s41568-019-0116-x
Barber, D. L. et al. Tuberculosis following PD-1 blockade for cancer immunotherapy. Sci. Transl. Med. 11, eaat2702 (2019).
pubmed: 30651320 pmcid: 7372940 doi: 10.1126/scitranslmed.aat2702
Anastasopoulou, A., Ziogas, D. C., Samarkos, M., Kirkwood, J. M. & Gogas, H. Reactivation of tuberculosis in cancer patients following administration of immune checkpoint inhibitors: current evidence and clinical practice recommendations. J. Immunother. Cancer 7, 239 (2019).
pubmed: 31484550 pmcid: 6727332 doi: 10.1186/s40425-019-0717-7
Tezera, L. B. et al. Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-α. Elife 9, 52668 (2020).
doi: 10.7554/eLife.52668
Sharpe, A. H., Sher, A., Barber, D. L., Mayer-Barber, K. D. & Feng, C. G. CD4 T cells promote rather than control CD4 T cells promote rather than control tuberculosis in the absence of PD-1–mediated inhibition. J. Immunol. 6, 1598–1607 (2017).
Anand, K. et al. Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors. ESMO Open 5, e000866 (2020).
pubmed: 32817069 pmcid: 7437685 doi: 10.1136/esmoopen-2020-000866
Hartmann, F. J., et al. Multiplexed single-cell metabolic profiles organize the spectrum of cytotoxic human T cells. Preprint at bioRxiv https://doi.org/10.1101/2020.01.17.909796 (2020).
Hu, Z. et al. MetaCyto: a tool for automated meta-analysis of mass and flow cytometry data. Cell Rep. 24, 1377–1388 (2018).
pubmed: 30067990 pmcid: 6583920 doi: 10.1016/j.celrep.2018.07.003
Newman, M. E. J. Finding community structure in networks using the eigenvectors of matrices. Phys. Rev. E 74, 036104 (2006).
doi: 10.1103/PhysRevE.74.036104
McInnes, L., Healy, J. & Melville, J. UMAP: uniform manifold approximation and projection for dimension reduction. Preprint at https://arxiv.org/abs/1802.03426 (2018).
Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 2017, 16878 (2017).
doi: 10.1038/s41598-017-17204-5

Auteurs

Erin F McCaffrey (EF)

Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.

Michele Donato (M)

Department of Medicine, Division of Biomedical Informatics Research, Stanford University School of Medicine, Stanford, CA, USA.
Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.

Leeat Keren (L)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Zhenghao Chen (Z)

Calico Life Sciences LLC, South San Francisco, CA, USA.

Alea Delmastro (A)

Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.

Megan B Fitzpatrick (MB)

Department of Pathology, University of Wisconsin, Madison, WI, USA.

Sanjana Gupta (S)

Department of Medicine, Division of Biomedical Informatics Research, Stanford University School of Medicine, Stanford, CA, USA.
Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.

Noah F Greenwald (NF)

Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.

Alex Baranski (A)

Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.

William Graf (W)

Division of Biology and Bioengineering, California Institute of Technology, Pasadena, CA, USA.

Rashmi Kumar (R)

Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.

Marc Bosse (M)

Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.

Christine Camacho Fullaway (CC)

Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.

Pratista K Ramdial (PK)

Africa Health Research Institute, University of KwaZulu-Natal, Durban, South Africa.

Erna Forgó (E)

Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.

Vladimir Jojic (V)

Calico Life Sciences LLC, South San Francisco, CA, USA.

David Van Valen (D)

Division of Biology and Bioengineering, California Institute of Technology, Pasadena, CA, USA.

Smriti Mehra (S)

Texas Biomedical Research Institute, San Antonio, TX, USA.

Shabaana A Khader (SA)

Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.

Sean C Bendall (SC)

Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.

Matt van de Rijn (M)

Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.

Daniel Kalman (D)

Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.

Deepak Kaushal (D)

Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA.

Robert L Hunter (RL)

Department of Pathology and Laboratory Medicine, University of Texas Health Sciences Center at Houston, Houston, TX, USA.

Niaz Banaei (N)

Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Division of Infectious Diseases & Geographic Medicine, Department of Medicine, Stanford University, Stanford, CA, USA.

Adrie J C Steyn (AJC)

Africa Health Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.

Purvesh Khatri (P)

Department of Medicine, Division of Biomedical Informatics Research, Stanford University School of Medicine, Stanford, CA, USA.
Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.

Michael Angelo (M)

Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA. mangelo0@stanford.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH